T3 · Product exporter position

Germany exports of Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions (HS 300212)

See where Germany stands in blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions: export scale, destination breadth, market position, growth, and reported trade history.

Exporter DEUHS6 300212Latest year 2024Growing

Latest exports

$9.5BLatest observed lane total

Destination markets

170Reported active markets

Three-year growth

+9.7%Annualized change

Destination HHI

1,229Destination concentration

Weighted share

29.1%Reported market position

Exporter evidence

How strong is Germany in Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions?

Reported exporter totals and calculated indicators for HS 300212. Values retain their observed coverage period.

Exporter scale

Latest exports$9.5B
Current 2024 exports$9.5B
Three-year average$8.7B
Historical peak$11.0B

Market position

Active destinations170
Destination HHI1,229
Weighted share29.1%
Share change+0 pp

Competitiveness

Three-year growth+9.7%
Volatility0.5
Maximum drawdown23.6%
TrendGrowing
MeasureValueWhat it describes
ExporterGermanyCountry represented by this profile
Latest observed exports$9.5BSum of latest observed destination-lane values
Current 2024 exports$9.5BCommon-year comparison where reported
Three-year growth+9.7%Annualized change in exporter totals
Five-year growth+7.5%Annualized change in exporter totals
Leading destinationUSADestination with the largest observed export value
Leading destination share29.5%Share of observed exporter totals
Destination concentration1,229HHI across destination markets
Weighted share change+0 ppValue-weighted latest change in market share
Limited-history lanes2.7%Share of lanes with shorter history

Destination markets

Where does Germany sell blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions?

Leading destination observations ranked by reported export value, with market position and access context.

DestinationLatest exportsMarket shareGrowthAccessSignal
USA, Puerto Rico and US Virgin Islands$2.8B33.2%+13.9%0% tariffAccelerating
Switzerland, Liechtenstein$1.3B24.4%+20.5%FTA reportedAccelerating
Austria$695.0M18.6%+21.5%FTA reportedGrowing
Sweden$494.2M45.7%+17%FTA reportedGrowing
Italy$334.8M22.9%+4.1%FTA reportedAccelerating
Spain$312.0M19.7%+10.8%FTA reportedAccelerating
France$310.7M21.7%-6.5%FTA reportedGrowing
Ireland$261.1M23.8%+10.8%FTA reportedAccelerating
China$252.2M10%-17.9%0.3% tariffGrowing
Belgium$222.5M12.7%+9.3%FTA reportedAccelerating
United Kingdom$206.4M27.4%-11.5%FTA reportedSlowing
Japan$159.0M25.8%+13.6%FTA reportedAccelerating
Canada$112.0M19%-9.1%FTA reportedAccelerating
Australia$108.1M9.2%+18.8%0.1% tariffGrowing
Iran (Islamic Republic of)$100.5M40.3%+6.8%0.6% tariffStable

Destination

USA, Puerto Rico and US Virgin Islands

Latest exports
$2.8B
Market share
33.2%
Growth
+13.9%
Access
0% tariff
Signal
Accelerating

Destination

Switzerland, Liechtenstein

Latest exports
$1.3B
Market share
24.4%
Growth
+20.5%
Access
FTA reported
Signal
Accelerating

Destination

Austria

Latest exports
$695.0M
Market share
18.6%
Growth
+21.5%
Access
FTA reported
Signal
Growing

Destination

Sweden

Latest exports
$494.2M
Market share
45.7%
Growth
+17%
Access
FTA reported
Signal
Growing

Destination

Italy

Latest exports
$334.8M
Market share
22.9%
Growth
+4.1%
Access
FTA reported
Signal
Accelerating

Destination

Spain

Latest exports
$312.0M
Market share
19.7%
Growth
+10.8%
Access
FTA reported
Signal
Accelerating

Destination

France

Latest exports
$310.7M
Market share
21.7%
Growth
-6.5%
Access
FTA reported
Signal
Growing

Destination

Ireland

Latest exports
$261.1M
Market share
23.8%
Growth
+10.8%
Access
FTA reported
Signal
Accelerating

Destination

China

Latest exports
$252.2M
Market share
10%
Growth
-17.9%
Access
0.3% tariff
Signal
Growing

Destination

Belgium

Latest exports
$222.5M
Market share
12.7%
Growth
+9.3%
Access
FTA reported
Signal
Accelerating

Destination

United Kingdom

Latest exports
$206.4M
Market share
27.4%
Growth
-11.5%
Access
FTA reported
Signal
Slowing

Destination

Japan

Latest exports
$159.0M
Market share
25.8%
Growth
+13.6%
Access
FTA reported
Signal
Accelerating

Destination

Canada

Latest exports
$112.0M
Market share
19%
Growth
-9.1%
Access
FTA reported
Signal
Accelerating

Destination

Australia

Latest exports
$108.1M
Market share
9.2%
Growth
+18.8%
Access
0.1% tariff
Signal
Growing

Destination

Iran (Islamic Republic of)

Latest exports
$100.5M
Market share
40.3%
Growth
+6.8%
Access
0.6% tariff
Signal
Stable

Price intelligence

How does Germany's price position vary?

Price comparisons are shown where market-level unit-value observations are available. They describe reported trade values and quantities, not quoted selling prices.

Highest reported price

Republic of Moldova: $14.6M / ton.

Lowest reported price

Papua New Guinea: $88.0 / ton.

Median price

$495.6K / ton across reported markets.

Export trend

Reported export history

Annual observations for Germany and HS 300212 where available.

YearExportsYear-on-year changeActive destinations
2012$3.0BNot reported176
2013$3.4B+15.3%175
2014$3.8B+11%175
2015$3.7B-4%175
2016$4.2B+15.7%174
2017$5.6B+31.6%170
2018$5.6B+0%163
2019$6.6B+18.3%165
2020$7.0B+6.6%168
2021$7.2B+2.2%170
2022$7.4B+2.7%165
2023$9.1B+23.1%168
2024$9.5B+4.5%170

Exporter context

Germany economy and trade network

The exporter profile adds country-level trade and structural context to the selected product position. These indicators describe the country overall and are not limited to HS 300212.

Germany has reported exports of $1.6T and a trade balance of $239.2B in 2024.

Available structural indicators include 64.1% trade openness, 22.1% investment, and 1,080 active trade partners.

Reported values

Export totals and destination values describe reported merchandise trade for the stated exporter, HS6 classification, and available year.

Calculated indicators

Growth, concentration, weighted share, volatility, drawdown, and price comparisons are calculated from reported observations.

Coverage

Missing values remain “Not reported”. Country-level indicators are presented separately from product-level observations.

Frequently asked questions

Questions about Germany blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions exports

Quick answers based on the figures and coverage shown on this page.

How strong is this exporter?

Use latest exports, destination breadth, growth, concentration, and weighted share together rather than relying on one measure.

Which markets are most important?

The destination table ranks reported markets by the latest observed export value.

Does the price section show quotes?

No. It summarizes reported trade value and quantity observations converted to unit values.

What should be checked next?

Compare this exporter with buyer markets, corridors, and the product overview before making a commercial decision.